Skip to main content

Medicinova Inc

MNOV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001226616

In the last 90 days, Medicinova Inc insiders filed 0 open-market purchases and 1 sale; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.84M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Medicinova Inc changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of MNOV: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders2633+7
Shares5.13M5.26M+128.9K (+2.5%)
Value$6.49M$6.88M+$393.9K (+6.1%)

New holders (9)

Institutions that held Medicinova Inc at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to MNOV in Q4 2025
InstitutionSharesValue% of portfolio
Jane Street Group, LLC163,096$213.7K0.00%
Two Sigma Investments, LP39,736$52.1K0.00%
Lantern Wealth Advisors, LLC30,000$39.3K0.02%
Goldman Sachs Group Inc26,480$34.7K0.00%
StoneX Group Inc.19,200$25.2K0.00%
Two Sigma Advisers, LP13,500$17.7K0.00%
Buckingham Strategic Partners10,000$13.1K0.00%
Advisor Group Holdings, Inc.66$860.00%
DRW Securities, LLC3,800––

Sold out (2)

Institutions that held Medicinova Inc at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of MNOV in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
FMR LLC50$63
Royal Bank of Canada6$0